<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Potentially lethal <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> (PLVAs) occur frequently in survivors after <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and are increasingly recognized in other forms of structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>This study investigated the prevalence and prognostic significance of PLVAs in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001635'>heart failure</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Data concerning demographics, etiology of <z:hpo ids='HP_0001635'>heart failure</z:hpo>, NYHA functional class, biochemical variables, electrocardiographic and echocardiographic findings, and medical treatments were collected by reviewing hospital medical records from 1080 patients with NYHA II-IV and a left ventricular (LV) ejection fraction â‰¤ 45% </plain></SENT>
<SENT sid="3" pm="."><plain>PLVAs were defined as multi-focal ventricular ectopy (&gt; 30 beats/h on Holter monitoring), bursts of <z:mp ids='MP_0009732'>ventricular premature beats</z:mp>, and nonsustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo>-cause mortality, <z:hpo ids='HP_0001699'>sudden death</z:hpo>, and rehospitalization due to worsening <z:hpo ids='HP_0001635'>heart failure</z:hpo>, or cardiac transplantation during 5-year follow-up after discharge were recorded </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The occurrence rate of PLVAs in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> was 30.2%, and increased with age; 23.4% in patients &lt; 45 years old, 27.8% in those between 45 - 65 years old, and 33.5% in patients &gt; 65 years old (P = 0.033) </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with PLVAs had larger LV size and lower ejection fraction (both P &lt; 0.01) and higher <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality (P = 0.014) during 5-year follow-up than those without PLVAs </plain></SENT>
<SENT sid="7" pm="."><plain>Age (OR 1.041, 95%CI 1.004 - 1.079, P = 0.03) and LV end-diastolic dimension (OR 1.068, 95%CI 1.013 - 1.126, P = 0.015) independently predicted the occurrence of PLVAs </plain></SENT>
<SENT sid="8" pm="."><plain>And PLVA was an independent factor for <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality (RR 1.702, 95%CI 1.017 - 2.848, P = 0.031) and <z:hpo ids='HP_0001699'>sudden death</z:hpo> (RR 1.937, 95%CI 1.068 - 3.516, P = 0.030) in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: PLVAs are common and exert a negative impact on long-term clinical outcome in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> </plain></SENT>
</text></document>